N@N

Market Maker Surveillance Report. MDGN, MSON, TXI, JCTCF, AFFY, ASUR, Winning Stocks With Lowest Price Friction For Thursday,

^{Published on 2012-07-12 18:00:38 - WOPRAI}
 

July 12, 2012 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Thursday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Thursday there were 3856 companies with "abnormal" market making, 1656 companies with positive Friction Factors and 3474 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Thursday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. Medgenics Inc (OTCBB:MDGN), Misonix Inc (NASDAQ:MSON), Texas Industries Inc (NYSE:TXI), Jewett-Cameron Trading Company Ltd (NASDAQ:JCTCF), Affymax Inc (NASDAQ:AFFY), Asure Software Inc (NASDAQ:ASUR). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

  Symbol  Change    Percent   Buy Volume   Buy %%    Sell Volume  Sell %%   Net Volume   Friction
  MDGN    $2.350    18.58%    88,850       30.60%    74,995       25.83%    13,855       59      
  MSON    $0.300    11.88%    43,140       56.66%    33,002       43.34%    10,138       338     
  TXI     $4.970    13.06%    440,842      29.44%    396,853      26.51%    43,989       89      
  JCTCF   $2.330    25.89%    37,014       49.81%    31,121       41.88%    5,893        25      
  AFFY    $2.290    19.16%    2,001,012    51.02%    1,854,344    47.28%    146,668      640     
  ASUR    $1.070    17.31%    74,452       66.33%    34,478       30.71%    39,974       374     

For example, the chart above shows MDGN with a dollar gain Thursday of $2.35000 and a Friction Factor of 59 shares. That means that it only took 59 more shares of buying than selling to move MDGN higher by one penny. The Market Makers are currently allowing the stock to rise quickly (low friction). The combination of low friction and positive market direction can drive prices higher much faster than normal.

Medgenics Inc (OTCBB:MDGN) - Medgenics, Inc., a biopharmaceutical company, through its subsidiary Medgenics Medical Israel Ltd., engages in the research and development of products in the field of biotechnology and associated medical equipment. Its Biopump platform technology allows patients to produce their natural human protein therapy for the treatment of a range of chronic diseases, such as anemia and hepatitis C. The company develops EPODURE, a Phase I/II clinical trial product for the treatment of chronic renal anemia; and INFRADURE for the treatment of hepatitis C. It also develops a pipeline of products based on its Biopump technology, such as clotting Factor VIII for the treatment of hemophilia. The companys platform technology also has the potential to treat a range of other therapeutic areas, such as multiple sclerosis, pediatric growth hormone deficiency/muscular atrophy, diabetes, arthritis, wound healing, obesity, chronic pain, and cancer recovery. Medgenics, Inc. was founded in 2000 and is based in Vienna, Virginia.

Misonix Inc (NASDAQ:MSON) - Misonix, Inc., together with its subsidiaries, designs, develops, manufactures, and markets therapeutic ultrasonic medical devices and laboratory equipment worldwide. The company operates in two segments, Laboratory and Scientific Products, and Medical Devices. The Laboratory and Scientific Products segment offers Sonicator ultrasonic liquid processors; Aura ductless fume enclosures for filtration of gaseous contaminates; Labcaire autoscope and Guardian endoscope disinfectant systems, which controls and eliminates hazardous vapors, noxious odors, and particulates in the laboratory; and Jet AER autoscope, a reprocessing, disinfecting, and rinsing equipment. The Medical Devices segment provides Auto Sonix ultrasonic cutting and coagulatory system, ultrasound systems, replacement transducers, ultrasonic lithotriptor, ultrasonic neuroaspirator used for neurosurgery, and soft tissue aspirator used primarily for the cosmetic surgery market. It also offers ISIS systems for the protection of personnel, products, and the environment from airborne hazards; and Sonablate 500 for the ablation of cancerous tissue in the prostate. The company primarily serves medical, pharmaceutical, semiconductor, biotechnology, and forensic industries. Its customers include end users, such as doctors, hospitals, and distributors. The company markets its products through direct salespersons, distributors, manufacturing representatives, and catalog listings. Misonix was founded in 1959 and is based in Farmingdale, New York.

Texas Industries Inc (NYSE:TXI) - Texas Industries, Inc., together with its subsidiaries, engages in the production and supply of heavy construction materials in the United States. The company operates in three segments: Cement, Aggregates, and Consumer Products. The Cement segment produces gray portland cement products, as well as specialty cements, such as masonry and oil well cements. The Aggregates segment offers natural aggregates, including sand, gravel, and crushed limestone products; and expanded shale and clay lightweight aggregates. The Consumer Products segment provides ready-mix concrete, packaged concrete mix, mortar, sand, and related products. The company serves the public works, residential, commercial, retail, and industrial and institutional construction sectors, as well as the oil and gas industry. Texas Industries, Inc. was founded in 1946 and is based in Dallas, Texas.

Jewett-Cameron Trading Company Ltd (NASDAQ:JCTCF) - Jewett-Cameron Trading Company, Ltd., through its subsidiaries, engages in the warehouse distribution and direct sale of wood products and specialty metal products to home centers and other retailers primarily in the United States. It operates in four segments: Industrial Wood Products; Lawn, Garden, Pet, and Other; Seed Processing and Sales; and Industrial Tools and Clamps. The Industrial Wood Products segment processes and distributes industrial wood products; and provides treated plywood to boat manufacturers and the transportation industry. The Lawn, Garden, Pet, and Other segment wholesales wood products, including fencing and landscape timbers; and manufactures and distributes specialty metal products comprising dog kennels, proprietary gate support systems, perimeter fencing, and greenhouses. The Seed Processing and Sales segment processes, distributes, and sells agricultural seeds to distributors. The Industrial Tools segment imports and distributes products, including pneumatic air tools, industrial clamps, and saw blades. The company was founded in 1953 and is headquartered in North Plains, Oregon.

Affymax Inc (NASDAQ:AFFY) - Affymax, Inc., a biopharmaceutical company, engages in the development of drugs for the treatment of serious and life-threatening conditions. The company is developing Hematide, which is in Phase III clinical trials for the treatment of anemia associated with chronic renal failure. Hematide is a synthetic peptide-based erythropoiesis stimulating agent designed to stimulate production of red blood cells. Affymax, Inc. has strategic alliance agreements with Takeda Pharmaceutical Company Limited and Nektar Therapeutics AL, Corporation to manufacture, develop, and commercialize Hematide. The company was founded in 2001 and is based in Palo Alto, California.

Asure Software Inc (NASDAQ:ASUR) - Asure Software, Inc. provides workforce management software and services. Its software empowers small to mid-size organizations and divisions of large enterprises to operate efficiently, increase worker productivity, and reduce costs. The company offers products that optimize workforce time and attendance tracking, benefits enrollment and tracking, pay stubs and W2 documentation, and meeting and event management. It was formerly known as Forgent Networks, Inc. and changed its name to Asure Software, Inc. in December 2009. The company was founded in 1985 and is headquartered in Austin, Texas with additional offices in Warwick, Rhode Island, Vancouver, and British Columbia, as well as in Mumbai, India.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net